| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/25/2008 | EP1935902A1 Reagent for measuring clotting time and method for manufacturing the reagent |
| 06/25/2008 | EP1935901A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1935430A1 Modified coagulation factors with prolonged in vivo half-life |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935244A1 Animal model of schizophrenia |
| 06/25/2008 | EP1935243A1 Saspase knockout animal |
| 06/25/2008 | EP1935242A1 Transgenic animal model |
| 06/25/2008 | EP1934606A2 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators |
| 06/25/2008 | EP1934598A2 Treatment and diagnosis of obligate intracellular pathogens |
| 06/25/2008 | EP1934372A2 Ssb - polymerase fusion proteins |
| 06/25/2008 | EP1934367A1 Molecular method for diagnosis of prostate cancer |
| 06/25/2008 | EP1934364A2 Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
| 06/25/2008 | EP1934363A2 Recurrent gene fusions in prostate cancer |
| 06/25/2008 | EP1934361A2 Methods for rejuvenating cells in vitro and in vivo |
| 06/25/2008 | EP1934360A2 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
| 06/25/2008 | EP1934359A2 Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 06/25/2008 | EP1934358A2 Transgenic rosa26-luciferase mice for bioluminescent imaging |
| 06/25/2008 | EP1934356A1 Astaxanthine biosynthesis in eukaryotes |
| 06/25/2008 | EP1934355A2 Means and methods to enhance the production of vinblastine and vincristine in catharanthus roseus |
| 06/25/2008 | EP1934354A2 Methods for producing hybrid seed |
| 06/25/2008 | EP1934353A2 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15rbeta/gamma, and hyperagonist (ilralpha sushi-il 15) fusion proteins |
| 06/25/2008 | EP1934352A2 Microbiological production of 3-hydroxypropionic acid |
| 06/25/2008 | EP1934351A2 Abiotic stress tolerant gene from avicennia marina encoding a protein |
| 06/25/2008 | EP1934350A2 Polyoleosins |
| 06/25/2008 | EP1934349A1 Bacterial delivery of biologically active polypeptides |
| 06/25/2008 | EP1934348A1 Compositions for silencing the expression of vdac1 and uses thereof |
| 06/25/2008 | EP1934347A2 Method and formulation for the extraction of nucleic acids from any complex starting materials |
| 06/25/2008 | EP1934346A1 Gpr22 and methods relating thereto |
| 06/25/2008 | EP1934345A2 Modification of rna, producing an increased transcript stability and translation efficiency |
| 06/25/2008 | EP1934344A1 Novel gene sms 37 |
| 06/25/2008 | EP1934343A2 Selective posttranslational modification of phage-displayed polypeptides |
| 06/25/2008 | EP1934341A1 Fusion proteins having a modulated half-life in plasma |
| 06/25/2008 | EP1934329A2 Translation enhancer-element dependent vector systems |
| 06/25/2008 | EP1934259A2 Nanobodies and polypeptides against egfr and igf-ir |
| 06/25/2008 | EP1934256A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 06/25/2008 | EP1934250A2 Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| 06/25/2008 | EP1933882A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 06/25/2008 | EP1933880A2 Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases |
| 06/25/2008 | EP1933871A2 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 06/25/2008 | EP1933857A2 Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
| 06/25/2008 | EP1933850A2 Aptamers as agonists |
| 06/25/2008 | EP1933614A2 Sucrose biosensors and methods of using the same |
| 06/25/2008 | EP1877575A4 System for producing synthetic promoters |
| 06/25/2008 | EP1766018A4 Anther specific promoters and uses thereof |
| 06/25/2008 | EP1689849A4 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 06/25/2008 | EP1667730A4 Compositions and methods for treating inflammatory lung disease |
| 06/25/2008 | EP1660631A4 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 06/25/2008 | EP1616950B1 Peptide having htlv-1-specific ctl-inducing activity |
| 06/25/2008 | EP1572911A4 Cloning of cytochrome p450 genes from nicotiana |
| 06/25/2008 | EP1474526B1 Enzyme activation protease assay |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |
| 06/25/2008 | EP1425404B1 Vaccinia virus mva-e3l-knockout-mutants and use thereof |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1336657B1 Process for producing coenzyme q 10 |
| 06/25/2008 | EP1306438B1 Novel carbonyl reductase, gene thereof and method of using the same |
| 06/25/2008 | EP1230261B1 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1179594B1 Ribonucleoprotein complex in paramyxovirus |
| 06/25/2008 | EP1173623B1 Solid medium and process for the storage and rapid purification of nucleic acid |
| 06/25/2008 | EP1171609B1 Lipoxygenase proteins and polynucleotides encoding the same |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1064387B1 Limanthes oil genes |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP0977894B1 Method and kit for identifying antibiotic-resistant strains of bacteria |
| 06/25/2008 | EP0922226B2 Process for determining the status of an organism by peptide measurement |
| 06/25/2008 | EP0885958B1 Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0851920B1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208438A Method of treating an inflammatory disease by double stranded ribonucleic acid |
| 06/25/2008 | CN101208437A Biosensors for detecting macromolecules and other analytes |
| 06/25/2008 | CN101208435A Improved expression elements |
| 06/25/2008 | CN101208434A Transformed plants accumulating mono- and/or sesquiterpenes |
| 06/25/2008 | CN101208433A Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 06/25/2008 | CN101208432A Improved methods for the production of stably transformed, fertile zea mays plants |
| 06/25/2008 | CN101208431A Compositions and methods for the diagnosis and treatment of tumor |
| 06/25/2008 | CN101208430A Method of constructing plant having nodules with high nitrogen fixation activity |
| 06/25/2008 | CN101208427A Methods and compositions for amino acid production |
| 06/25/2008 | CN101208108A Gene therapy for spinal disorders |
| 06/25/2008 | CN101205558A Banana wilt bacterium molecule detecting genes and detecting method thereof |
| 06/25/2008 | CN101205553A Method for preparing recombinant glossy ganoderma immunomodulatory protein |
| 06/25/2008 | CN101205546A Electroporation method for streptococcus mutans |
| 06/25/2008 | CN101205545A Recombinant baculoviral for expressing grass carp reovirus external casing protein and construction thereof |
| 06/25/2008 | CN101205544A Tumor targeting recombinant newcastle disease viruses and construction method thereof |
| 06/25/2008 | CN101205543A Special carrier for improving utilization ratio of plant nitrogen nutrition and use thereof |
| 06/25/2008 | CN101205542A Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof |
| 06/25/2008 | CN101205541A Recombinant expression carrier and method for high-yield of 1,3-propanediol by fermenting glycerin using host cell converted thereby |
| 06/25/2008 | CN101205540A Cultivated silkworm glucosyltransferase genes |
| 06/25/2008 | CN101205539A Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines |
| 06/25/2008 | CN101205538A Clone, expression and use of Schistosoma Japonicum signal transduction protein Sjwnt-4 gene |
| 06/25/2008 | CN101205537A Method for acquiring transgenic gramineae farm crop capable of being selectively eliminated |
| 06/25/2008 | CN101205536A Method for enriching methylate DNA from complete genome and chromatography column group used therefor |
| 06/25/2008 | CN101205535A Method for providing recombinant baculovirus with polyhedrosis coatings |
| 06/25/2008 | CN101205534A Method for inhibiting plant infection of rice dwarf virus |
| 06/25/2008 | CN101205531A Fetus liver stroma cell strain expressing alkaline fibroblast growth factor and uses thereof |
| 06/25/2008 | CN101205524A Method for treating industrial waste and fermentation production of microbial oil by microorganism as well as special strain thereof |
| 06/25/2008 | CN101205252A Soluble V E G F R bifunctional chimera receptor, preparation method and uses thereof |